PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,651 stories, page 600 of 745

Advanced search
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02123758: A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

iX BIOPHARMA: Will These Upcoming Milestones Re-rate The Stock?

NextInsightOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ABVX Stock Rockets 28% After Abivax Eases Drug Safety Concerns With Fresh Clinical Data

StocktwitsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

United Parcel Service, Inc. (UPS) Eyes Medicines and Pharmaceutical Opportunities with $48M Investment

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Editorial | Independent drug approvals are key to Hong Kong’s biotech ambitions

South China Morning PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Does CRISPR Therapeutics’ (CRSP) Russell Index Debut Quietly Reframe Its Biotech Growth Narrative?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech ETF (BBC) touches a new 52-week high

MSNOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Hidden Reason Biotech Breakthroughs Keep Getting Delayed

inc.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Texas Biomed teams up with UK-based biotech company to fight screwworm

San Antonio ReportOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Phase 3 SIGMA Trial of Safusidenib Is Initiated for IDH1-Mutant Glioma

Targeted OncologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Roche collaborates with Nurix Therapeutics to develop BTK degrader bexobrutideg for cancer and immune diseases

Select ScienceOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Lung-Focused Celea Secures $180M for Pivotal Test of Pulmonary Fibrosis Drug

MedCity NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MEPs supportive of draft Biotech report, but divisions over incentives remain

EU ReporterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

IHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors?

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Viatris Inc. is One of the 10 Most Undervalued NASDAQ Stocks to Buy Right Now

sekbernews.idOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks Are Surging in 2026. This One Stands Out After a Pullback.

TheStreet ProOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Collegium Pharmaceutical, Inc. – FWB:354

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of China Resources Jiangzhong Pharmaceutical Co., Ltd. Class A – SSE:600750

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Roche Reports Positive Phase 3 Results for Divarasib in Previously Treated KRAS G12C NSCLC

OncodailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of CTT Pharmaceutical Holdings, Inc. – OTC:CTTH

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Flags Three Beauty Creams Over Toxic Mercury and Lead Levels

BizzBuzzOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA warns against three beauty creams after tests detect excessive mercury, lead levels

The Hans IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fidelity Health Care vs. State Street Biotech: Which ETF Fits Your Portfolio Best?

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GNI Group Acquires Ayumi Pharmaceutical For JPY 44.8 Billion (About $276 Million)

Pulse 2.0Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Viatris (VTRS): Most Undervalued NASDAQ Stocks to Buy Right Now

Insider MonkeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Viatris (VTRS): Most Undervalued NASDAQ Stocks to Buy Right Now

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity

AOL.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

883035 Forecast — Price Target — Prediction for 2027

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Collegium Pharmaceutical, Inc. – NASDAQ:COLL

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CPHI South East Asia 2026 to drive pharma partnerships across ASEAN

Vietnam Investment Review - VIROriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US FDA sends 25 letters to telehealth companies over claims on compounded weight-loss drugs

MSNOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

"Needs To Be Strengthened": Maharashtra Food Regulator Chief On Manpower

NDTVOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra bans Pak beauty cream with mercury & lead level above safe limit, 18 women fall ill

Business TodayOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Taiyen Biotech Co. Ltd. – TWSE:1737

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech ETF (BBC) touches a new 52-week high

MSNOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fjarde AP Fonden Fourth Swedish National Pension Fund Boosts Stake in Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Zhejiang Jolly Pharmaceutical Co., Ltd. Class A – SZSE:300181

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zhejiang Huahai Pharmaceutical Sees H1 Net Profit Up 85-95% Y/Y

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA probes anesthesia-linked neurological complications in some patients of Venezuelan ancestry

MSNOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Video #254 - EXCITING NEWS - Apitegromab Phase 3 Trial Updates Raven Johnson (ZpFMNQeNv4)

MshaleOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GSK acquires Nuvalent for $10.6 billion in oncology push

qz.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kazakhstan, India Strengthen Pharmaceutical Partnership with New Investment Push

Caspian PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Residents in eastern Congo cling to hope as a new Ebola treatment trial begins

The New Indian ExpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How Much Could $1,000 Invested in Viking Therapeutics Be Worth by 2030?

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Zhejiang Hisoar Pharmaceutical Co., Ltd. Class A – SZSE:002099

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Zhejiang Jolly Pharmaceutical Co., Ltd. Class A – SZSE:300181

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class A – SSE:600196

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Touyun Biotech Group Limited – HKEX:1332

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Touyun Biotech Group Limited – HKEX:1332

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ETFs Investing in Dizal Pharmaceutical Co Ltd. Class A Stocks

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Central Pharmaceutical JSC No. 3 – HNX:DP3

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Touyun Biotech Group Limited – HKEX:1332

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Psychedelic Nation? Psilocybin Treatments Offer New Hope for People Prozac Hasn’t Helped

The Daily UpsideOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Aribio Accelerates Global Commercialization of Alzheimers Drug AR1001 with Strategic Investment

Aju PressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Doctor at OU Health leads new clinical trial for stage 1 lung cancer patients

AOL.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Mochida Pharmaceutical Co., Ltd. – TSE:4534

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SOUN Stock Rebounds After LivePerson Deal: Retail Bulls Bank On AI Opportunity With Expanded Fortune 100 Client Base

StocktwitsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Meribank Biotech Co Ltd – TPEX:4724

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Existing drug could speed new treatment for rare liver cancer

QazinformOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BIIB Stock Ends 3% Higher — Why This Strategist Picks Biogen Over Other Biotech Peers

StocktwitsOriginal source